Analysis of HLA antigens in Turkish sarcoidosis patients

Southern Medical Journal

Volumn 100, Issue 4, 2007, Pages 356-359

  Bilir, Muammer ^a   Sipahi, Sevtap ^a   Yilmaz, Erkan ^a   Midilli, Kenan ^a   Yanardag, Halil ^a   Cagatay, Tulin ^a   Demirci, Sabriye ^a   Karayel, Tuncer ^a   Erdogan, Ergun ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ethnic group; HLA antigens; Sarcoidosis

Indexed keywords

HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA A25 ANTIGEN; HLA A69 ANTIGEN; HLA A9 ANTIGEN; HLA ANTIGEN; HLA B12 ANTIGEN; HLA B22 ANTIGEN; HLA B38 ANTIGEN; HLA B49 ANTIGEN; HLA B7 ANTIGEN; HLA DR14 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GROUPS BY AGE; HLA SYSTEM; HUMAN; KIDNEY TRANSPLANTATION; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; SARCOIDOSIS; SEX RATIO; TURKEY (REPUBLIC);

ADULT; BIOPSY; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; PREVALENCE; SARCOIDOSIS; TURKEY;

EID: 34147134577     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31802f3763     Document Type: Article

References (14)

1. Schurmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861-864.
2. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747-760.
3. Tiwari JL, Terasiki PI. HLA and Disease Association. New York: Springer-Verlag, 1985;380-381.
4. Abe S, Yamaguchi E, Makimura S, et al. Association of HLA DR with sarcoidosis: correlation with clinical course. Chest 1987;92:488-490.
5. Martinetti M, Tinelli C, Kolek V, et al. The sarcoidosis map: a joint survey of clinical and immunogenetic findings in two European countries. Am Respir Crit Care Med 1995;152:557-564.
6. De Remee RA. The roentgenographic staging of sarcoidosis: historic and contemporary perspectives. Chest 1983;83:128-133.
7. Terasaki PI, McCleland JD. Microdroplet assay of human serum cytotxins. Nature 1964;204:998-1000.
8. Akokan G, Celikoglu S, Goksel FM, et al. Antigens in Turkish patients with sarcoidosis. N Engl J Med 1977;296:759.
9. Celik G, Sen E, Ulger AF, et al. Human leukocyte antigens A and B in Turkish patients with sarcoidosis [in Spanish]. Arch Bronchoneumol 2004;40:449-452.
10. Odum N, Milman N, Jakobsen BK, et al. HLA class II (DR, DP, DQ) in patients with sarcoidosis: evidence of an increased frequency of DRw6. Exp Clin Immunogenet 1991;8:227-232.
11. Lenhart K, Kolek V, Bartova A. HLA antigens associated with sarcoidosis. Dis Markers 1990;8:23-29.
12. Kunikane H, Abe S, Tsuneta Y, et al. Role of HLA DR antigens in Japanese patients with sarcoidosis. Am Rev Respir Dis 1987;135:688-691.
13. Berlin M, Fogdell-Hahn A, Olarup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601-1605.
14. Pasturenzi L, Martinentti M, Cuccia M, et al. HLA class I, II and III polymorphism in Italian patients with sarcoidosis: the Pavia-Padora Sarcoidosis Study Group. Chest 1993;104:1170-1175.